Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

The vaccine setback pushed the markets lower - Tuesday Review, October 13

The vaccine setback pushed the markets lower - Tuesday Review, October 13

Investors didn't enjoy the temporary halt in the progress of a COVID-19 vaccine

The US

The benchmarks disregarded the promising beginning of the latest earnings season and focused on the fact that another significant pharma company halted the trials of a potential #COVID-19 vaccine. USA30 fell 0.55% while USA500 was down 0.61%. TECH100 slipped 0.10%.

Crude Oil and Brent gained 0.4%, ending the session at $39.56 per barrel and $41.88.

Gold lost 1.8% to $1,894.60 per ounce.

The Dollar Index rose 0.5% to 93.55.

Asia and Australia

Japan225 lost 0.07% amid the hiccup in the trials of a potential COVID-19 #vaccine from Johnson & Johnson.

Down under, Australia200 gained 1.18%, after the country is seeking to resolve the ban imposed by China on the Australian coal imports.

USD/JPY gained 0.24% to 105.55.

Europe

Germany30 and UK100 lost 0.4% each. France40 fell 0.5%. The drop was caused by the fact that the new wave of infections could negatively impact the ongoing economic recovery.

EUR/USD traded at 1.1785 after it lost 0.2%.

Sources: reuters.com, investing.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com